Videre til indhold
  • Hjem
  • Services
    • Kapitalrejsninger
    • Børsnoteringer
    • Fusioner og opkøb
  • Transaktioner
  • Teamet
    • Om os
    • Kontakt
  • Vores tilgang
  • Hjem
  • Services
    • Kapitalrejsninger
    • Børsnoteringer
    • Fusioner og opkøb
  • Transaktioner
  • Teamet
    • Om os
    • Kontakt
  • Vores tilgang
  • EN
  • DA
  • SV
Investorer

Transaktioner

Alle transaktioner

Vi gennemfører forskellige transaktioner, der varierer i type, størrelse og struktur. Udforsk dem her.

  • Closed
  • 7. juni - 2024

Stenocare A/S

  • 5,400,000 DKK
  • Udnyttelse af warrants
  • 7. juni - 2024

Gemstone acted as financial advisor in Stenocare’s warrant exercise

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere
  • Closed
  • 11. august - 2023

DecideAct A/S

  • 12,000,000 DKK
  • Fortegningsemission
  • 11. august - 2023

Gemstone acted as finacial advisor in DecideAct’s rights issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.
  • Læs mere
  • Closed
  • 3. august - 2023

Qlife Holding AB

  • 4,600,000 SEK
  • Gældsfinansiering
  • 3. august - 2023

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Qlife has developed and patented the Egoo Health test platform, which integrates several technologies that potentially can test for a wide range of biomarkers and viruses – protein-based and molecular.
  • Læs mere
  • Closed
  • 30. maj - 2023

Sound Dimension AB

  • 1,200,000 SEK
  • Gældsfinansiering
  • 30. maj - 2023

Sound Dimension secures a bridge loan of 1.2 MSEK

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.
  • Læs mere
  • Closed
  • 15. november - 2022

Stenocare A/S

  • 11,000,000 DKK
  • Gældsfinansiering
  • 15. november - 2022

Gemstone act as financial advisor in Stenocares establishment of a convertible loan facility

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere
  • Closed
  • 9. marts - 2022

DecideAct A/S

  • 5,200,000 DKK
  • Rettet emission
  • 9. marts - 2022

Gemstone acted as financial advisor in DecideAct’s directed issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.
  • Læs mere
  • Closed
  • 16. september - 2021

Brain+ A/S

  • 15,000,000 DKK
  • Børsnoteringer
  • 16. september - 2021

Gemstone Capital acted as financial advisor for Brain+ in their IPO

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.
  • Læs mere
  • Closed
  • 30. august - 2021

Sound Dimension AB

  • 15,000,000 SEK
  • Børsnoteringer
  • 30. august - 2021

Gemstone Capital acted as financial advisor for Sound Dimension in their IPO

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.
  • Læs mere
  • Closed
  • 22. marts - 2021

Spermosens AB

  • 29,000,000 SEK
  • Børsnoteringer
  • 22. marts - 2021

Gemstone acted as financial advisor for Spermosens in their IPO

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.
  • Læs mere

Fortegningsemission

En fortegningsemission giver eksisterende ejere af en virksomhed prioritet til at investere yderligere i virksomheden, hvis de ønsker det.

  • Closed
  • 11. august - 2023

DecideAct A/S

  • 12,000,000 DKK
  • Fortegningsemission
  • 11. august - 2023

Gemstone acted as finacial advisor in DecideAct’s rights issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.
  • Læs mere
  • Closed
  • 11. maj - 2020

Stenocare A/S

  • 44,800,000 DKK
  • Fortegningsemission
  • 11. maj - 2020

Gemstone acted as financial advisor in Stenocare’s rights issue

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere
  • Closed
  • 19. maj - 2025

Prostatype Genomics

  • 49,500,000 SEK
  • Fortegningsemission
  • 19. maj - 2025

Gemstone acts as financial advisor in Prostatype Genomics’ Unit Rights Issue

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test Prostatype®. Prostatype® is a genetic test that provides a comprehensive assessment of the aggressiveness of prostate cancer.
  • Læs mere
  • Closed
  • 19. maj - 2025

Realfiction Holding AB

  • 17,500,000 SEK
  • Fortegningsemission
  • 19. maj - 2025

Gemstone acted as the Danish advisor in Realfiction’s rights issue

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.
  • Læs mere
  • Closed
  • 16. april - 2019

Menupay AB

  • 23,000,000 SEK
  • Fortegningsemission
  • 16. april - 2019

Gemstone acted as financial advisor for menupay in their rights issue

MenuPay was an international technology company, based in Denmark and listed in Sweden on Spotlight Stockmarket, that digitised the relationship between restaurants, businesses and their employees.
  • Læs mere
  • Closed
  • 24. april - 2023

Brain+ A/S

  • 15,700,000 DKK
  • Fortegningsemission
  • 24. april - 2023

Gemstone acted as financial advisor in Brain+’s unit rights issue

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.
  • Læs mere
  • Closed
  • 15. november - 2022

Spermosens AB

  • 24,000,000 SEK
  • Fortegningsemission
  • 15. november - 2022

Gemstone acted as joint financial advisor and joint bookrunner in Spermonsens’ rights issue

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.
  • Læs mere
  • Closed
  • 19. maj - 2025

Stenocare A/S

  • 29,700,000 DKK
  • Fortegningsemission
  • 19. maj - 2025

Gemstone acted as financial advisor in Stenocare’s Unit Rights Issue

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere
  • Closed
  • 19. maj - 2025

Sound Dimension AB

  • 8,100,000 SEK
  • Fortegningsemission
  • 19. maj - 2025

Gemstone was financial advisor in Sound Dimension’s unit rights issue

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.
  • Læs mere

Rettet emission

I en rettet emission fraviges de eksisterende ejeres fortegningsret til at tegne aktier, hvilket typisk gør den hurtigere at gennemføre end en fortegningsemission.

  • Closed
  • 9. marts - 2022

DecideAct A/S

  • 5,200,000 DKK
  • Rettet emission
  • 9. marts - 2022

Gemstone acted as financial advisor in DecideAct’s directed issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.
  • Læs mere
  • Closed
  • 21. marts - 2019

Realfiction Holding AB

  • 7,000,000 SEK
  • Rettet emission
  • 21. marts - 2019

Gemstone acted as the Danish advisor for Realfiction in their directed issue

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.
  • Læs mere
  • Closed
  • 1. december - 2017

Stenocare A/S

  • 2,000,000 DKK
  • Rettet emission
  • 1. december - 2017

Gemstone acted as financial advisor for Stenocare in a Private Placement

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere

Børsnoteringer

Når en virksomhed forbereder sig på en børsnotering, kan den søge at rejse kapital til vækst og sprede ejerskabet blandt aktionærerne og vælger ofte at gennemføre en IPO (Initial Public Offering).

  • Closed
  • 16. september - 2021

Brain+ A/S

  • 15,000,000 DKK
  • Børsnoteringer
  • 16. september - 2021

Gemstone Capital acted as financial advisor for Brain+ in their IPO

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.
  • Læs mere
  • Closed
  • 30. august - 2021

Sound Dimension AB

  • 15,000,000 SEK
  • Børsnoteringer
  • 30. august - 2021

Gemstone Capital acted as financial advisor for Sound Dimension in their IPO

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.
  • Læs mere
  • Closed
  • 22. marts - 2021

Spermosens AB

  • 29,000,000 SEK
  • Børsnoteringer
  • 22. marts - 2021

Gemstone acted as financial advisor for Spermosens in their IPO

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.
  • Læs mere
  • Closed
  • 25. november - 2020

DecideAct A/S

  • 18,500,000 DKK
  • Børsnoteringer
  • 25. november - 2020

Gemstone acted financial advisor for DecideAct in their IPO

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.
  • Læs mere
  • Closed
  • 21. september - 2018

Stenocare A/S

  • 18,600,000 DKK
  • Børsnoteringer
  • 21. september - 2018

Gemstone acted as financial advisor in Stenocare’s IPO

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere
  • Closed
  • 20. juni - 2017

Realfiction Holding AB

  • 21,500,000 SEK
  • Børsnoteringer
  • 20. juni - 2017

Gemstone was financial advisor for Realfiction in their IPO

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.
  • Læs mere
  • Closed
  • 19. maj - 2025

ExpreS2ion Biotech Holding AB

  • 18,000,000 SEK
  • Børsnoteringer
  • 19. maj - 2025

Gemstone acted as financial advisor in ExpreS2ion Biotech’s IPO

ExpreS2ion Biotechnologies has created a platform technology to enable the cost-effective and safe production of complex proteins, which are the active ingredient in new vaccines and thus also an important basis in diagnostics, research and development of these new vaccines.
  • Læs mere
  • Closed
  • 19. maj - 2025

Omnicar Holding AB

  • 14,000,000 SEK
  • Børsnoteringer
  • 19. maj - 2025

Gemstone was financial advisor for Omnicar in their IPO

OmniCar has developed a software solution for the car industry. The solution is developed for Citroën in Scandinavia and has been developed by OMI A/S (‘OMI’), a digital marketing agency started by OmniCar co-founder and board member Claus T. Hansen. OmniCar is a spin-off from OMI.
  • Læs mere
  • Closed
  • 19. maj - 2025

Freetrailer Group A/S

  • 14,000,000 DKK
  • Børsnoteringer
  • 19. maj - 2025

Gemstone acted as Financial advisor to Freetrailer in their IPO

Freetrailer has developed a digital platform that uses the Freelock electronic lock in combination with an combination with an application makes it possible to reserve, collect and return a trailer.
  • Læs mere

Udnyttelse af warrants

Virksomheder kan udstede warrants, som giver investorer og medarbejdere mulighed for at tegne nye aktier til en potentielt fordelagtig pris senere.

  • Closed
  • 7. juni - 2024

Stenocare A/S

  • 5,400,000 DKK
  • Udnyttelse af warrants
  • 7. juni - 2024

Gemstone acted as financial advisor in Stenocare’s warrant exercise

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere

Fusioner og opkøb

Transaktioner der involverer fusioner og opkøb, der omfatter køb og salg af virksomheder.

Der er ingen transaktioner inden for denne kategori

Gældsfinansiering

Kapital kan rejses gennem gæld, hvor transaktioner som konvertible lån og bridgelån er almindelige metoder.

  • Closed
  • 3. august - 2023

Qlife Holding AB

  • 4,600,000 SEK
  • Gældsfinansiering
  • 3. august - 2023

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Qlife has developed and patented the Egoo Health test platform, which integrates several technologies that potentially can test for a wide range of biomarkers and viruses – protein-based and molecular.
  • Læs mere
  • Closed
  • 30. maj - 2023

Sound Dimension AB

  • 1,200,000 SEK
  • Gældsfinansiering
  • 30. maj - 2023

Sound Dimension secures a bridge loan of 1.2 MSEK

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.
  • Læs mere
  • Closed
  • 15. november - 2022

Stenocare A/S

  • 11,000,000 DKK
  • Gældsfinansiering
  • 15. november - 2022

Gemstone act as financial advisor in Stenocares establishment of a convertible loan facility

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.
  • Læs mere
  • Closed
  • 11. august - 2023

DecideAct A/S

  • 5,000,000 DKK
  • Gældsfinansiering
  • 11. august - 2023

Gemstone acted as financial advisor in DecideAct’s convertible loan of 5 mDKK

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.
  • Læs mere

Financial and strategic advisors
to high caliber growth companies
in pursuit of market leadership.

Linkedin-in
Kontakt
  • +45 24 24 26 00
  • info@gemstonecapital.com
  • Strandvejen 102b, 2900 Hellerup
Transaktioner
  • Fortegningsemission
  • Rettet emission
  • Børsnoteringer
  • Udnyttelse af warrants
  • Fusioner og opkøb
  • Gældsfinansiering
  • Fortegningsemission
  • Rettet emission
  • Børsnoteringer
  • Udnyttelse af warrants
  • Fusioner og opkøb
  • Gældsfinansiering
  • Fortegningsemission
  • Rettet emission
  • Børsnoteringer
  • Udnyttelse af warrants
  • Fusioner og opkøb
  • Gældsfinansiering
  • Fortegningsemission
  • Rettet emission
  • Børsnoteringer
  • Udnyttelse af warrants
  • Fusioner og opkøb
  • Gældsfinansiering
Generelt
  • Vores tilgang
  • Om os
  • Kapitalrejsninger
  • Investorer
  • Privatlivspolitik
  • Cookie politik
  • Vores tilgang
  • Om os
  • Kapitalrejsninger
  • Investorer
  • Privatlivspolitik
  • Cookie politik
  • Vores tilgang
  • Om os
  • Kapitalrejsninger
  • Investorer
  • Privatlivspolitik
  • Cookie politik
  • Vores tilgang
  • Om os
  • Kapitalrejsninger
  • Investorer
  • Privatlivspolitik
  • Cookie politik

© 2025 Gemstone Capital – Designet af Aveo webmarketing

Close menu
  • Hjem
  • Services
    • Kapitalrejsninger
    • Børsnoteringer
    • Fusioner og opkøb
  • Transaktioner
  • Om os
    • Om os
    • Kontakt
  • Vores tilgang
Investors
  • EN
  • DA
  • SE
Luk menu
  • Hjem
  • Services
    • Kapitalrejsninger
    • Børsnoteringer
    • Fusioner og opkøb
  • Transaktioner
  • Om os
    • Om os
    • Kontakt
  • Vores tilgang
Investorer
  • EN
  • DA
  • SE